Cargando…

Reduced circulating growth hormone and insulin-like growth factor-1 and delayed growth of premature rats are aggravated by longer daily duration of chronic intermittent hypoxia exposure

OBJECTIVE: This study mainly aimed to investigate the effect of daily duration of chronic intermittent hypoxia (CIH) exposure on circulating growth hormone (GH)/insulin-like growth factor-1 (IGF-1) concentrations and body weight changes of premature rats. METHODS: 40 healthy male SD rats aged six we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chi, Du, Xiaowan, Li, Jingjing, Zhang, Junbo, Yin, Guoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869368/ https://www.ncbi.nlm.nih.gov/pubmed/36699292 http://dx.doi.org/10.3389/fped.2022.1008282

Ejemplares similares

ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022)

Influence of Full Oral Feeding Acquisition on Growth of Premature Infants
por: Chinea Jiménez, Bibiana, et al.
Publicado: (2022)

Significance of Intermittent Hypoxic Episodes in Premature Infants Prior to Discharge
por: Alalaiyan, Saleh, et al.
Publicado: (2023)

The Nexus of Prematurity, Birth Defects, and Intrauterine Growth Restriction: A Role for Plac1-Regulated Pathways
por: Fant, Michael E., et al.
Publicado: (2014)

Transient Intermittent Hypoxia Exposure Disrupts Neonatal Bone Strength
por: Kim, Gyuyoup, et al.
Publicado: (2016)

Stress Signals During Sucking Activity Are Associated With Longer Transition Time to Full Oral Feeding in Premature Infants
por: Yi, You Gyoung, et al.
Publicado: (2018)

Electrocardiographic Findings in Children With Growth Hormone Deficiency
por: Yılmaz, Münevver, et al.
Publicado: (2023)

Long acting growth hormone (LAGH), an update
por: Grillo, Margaret Steiner, et al.
Publicado: (2023)

OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency
por: Maniatis, Aristides K, et al.
Publicado: (2020)

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2021)

Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
por: Kondo, Chiori, et al.
Publicado: (2022)

The value of plasma insulin-like growth factor 1 and interleukin-18 in the diagnosis of bronchopulmonary dysplasia in premature infants
por: Huang, Lie, et al.
Publicado: (2022)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

ODP386 Growth Velocity and Growth Hormone Deficiency During Puberty
por: Currais, Carolina, et al.
Publicado: (2022)

Prematurity With Extrauterine Growth Restriction Increases the Risk of Higher Levels of Glucose, Low-Grade of Inflammation and Hypertension in Prepubertal Children
por: Ordóñez-Díaz, Maria D., et al.
Publicado: (2020)

Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity
por: Chen, Jing, et al.
Publicado: (2023)

Intermittent hypoxia in neonatal rodents affects facial bone growth
por: Pae, Eung-Kwon, et al.
Publicado: (2023)

SAT-LB12 Once-Weekly Somapacitan vs Daily Growth Hormone in Growth Hormone Deficiency: 2-Year Safety Results From Real 3, a Randomized Phase 2 Trial
por: Savendahl, Lars S, et al.
Publicado: (2020)

Factors Driving Patient Preferences for Growth Hormone Treatment in Japanese Children With Growth Hormone Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2021)

Quality of Life of Short-Statured Children Born Small for Gestational Age or Idiopathic Growth Hormone Deficiency Within 1 Year of Growth Hormone Treatment
por: Quitmann, Julia, et al.
Publicado: (2019)

Intermittent Hypoxia in Childhood: The Harmful Consequences Versus Potential Benefits of Therapeutic Uses
por: Serebrovskaya, Tatiana V., et al.
Publicado: (2015)

Psycho-Emotional and Behavioral Problems in Children With Growth Hormone Deficiency
por: Aryayev, Mykola, et al.
Publicado: (2021)

RF26 | PSAT150 Growth Outcomes From the Phase 2 and Phase 3 Studies of Once Weekly Somatrogon vs Daily Genotropin in Pediatric Patients With Growth Hormone Deficiency: Comparisons With Published Literature and an International Growth Study Database
por: Cara, Jose, et al.
Publicado: (2022)

Sub-Optimal Adherence With Daily Growth Hormones Increases With Each Year of Treatment in a US Commercial Claims Database
por: Loftus, Jane, et al.
Publicado: (2021)

PSAT104 Predicting Response to Growth Hormone Therapy with Pituitary Volume and The Growth Hormone Stimulation Test
por: McGuirk, Liam, et al.
Publicado: (2022)

OR17-5 Clinical and Genetic Features of Constitutional Delay of Growth and Puberty
por: Sales Barroso, Priscila, et al.
Publicado: (2019)

Case report: Tackling the complexities of an extremely premature newborn with intrauterine growth restriction and congenital metabolic disorders through a multidisciplinary approach
por: Roșca, Ioana, et al.
Publicado: (2023)

Intermittent Hypoxia in Preterm Neonates and Its Effect on Neonatal Morbidity and Mortality: A Systematic Review
por: Mandala, Vinod Kumar, et al.
Publicado: (2023)

SAT-102 Height Improvement with Recombinant Human Growth Hormone Therapy at Terminal Stage of Growth
por: Kim, Dae Hyun, et al.
Publicado: (2020)

Postnatal growth and gut microbiota development influenced early childhood growth in preterm infants
por: Tadros, Jocelyne S., et al.
Publicado: (2022)

OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial
por: Thornton, Paul, et al.
Publicado: (2019)

Extrauterine growth restriction in preterm infants: Postnatal growth pattern and physical development outcomes at age 3–6 years
por: Lan, Siyuan, et al.
Publicado: (2022)

Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats
por: Wang, Zhang, et al.
Publicado: (2013)

Intermittent Bi-Daily Sub-cutaneous Teriparatide Administration in Children With Hypoparathyroidism: A Single-Center Experience
por: Bernardor, Julie, et al.
Publicado: (2021)

Heterotaxy Syndrome: Discordant Growth
por: Yadav, Pratiksha, et al.
Publicado: (2021)

Effect of hip dysplasia on the development of the femoral head growth plate
por: Ren, Ningtao, et al.
Publicado: (2023)

Gut microbiota composition alteration analysis and functional categorization in children with growth hormone deficiency
por: Huang, Congfu, et al.
Publicado: (2023)

The Influence of Different Caregivers on Infant Growth and Development in China
por: Li, Qinrui, et al.
Publicado: (2017)

No Difference in Growth Outcomes up to 24 Months of Age by Duration of Exposure to Maternal Antiretroviral Therapy Among Children Who Are HIV-Exposed and Uninfected in Malawi
por: Toledo, Gabriela, et al.
Publicado: (2022)

OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qb3vgeuc26rsmcdtkbiud9nnk0